DYN - Dyne Therapeutics, Inc.

QQQ $ 454.82 $ 1.85 (0.41 %)

DIA $ 398.57 $ -1.87 (-0.47 %)

SPY $ 530.36 $ 0.23 (0.04 %)

TLT $ 91.26 $ -0.27 (-0.3 %)

GLD $ 225.37 $ 0.90 (0.4 %)

Previous Close

$ 27.68

Open

$ 30.58

Bid

$ 35.34 x 200

Ask

$ 35.39 x 300

Day's Range

$ 30.58 - $ 35.63

52 Week Range

$ 6.40 - $ 30.27

Volume

1,318,232

Average Volume

Market Cap

2.24B

Beta (5Y Monthly)

$ 0.85

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-02-2024	03-31-2024	10-Q
2	03-05-2024	12-31-2023	10-K
3	10-30-2023	09-30-2023	10-Q
4	08-03-2023	06-30-2023	10-Q
5	05-11-2023	03-31-2023	10-Q
6	03-02-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-04-2022	06-30-2022	10-Q
9	05-02-2022	03-31-2022	10-Q
10	03-10-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	05-06-2021	03-31-2021	10-Q
14	03-04-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Dyne Therapeutics Announces $300M Public O...
05/20/2024 20:01:52

Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming...

why-is-dyne-therapeutics-stock-soaring-on-monday

Why Is Dyne Therapeutics Stock Soaring On ...
05/20/2024 19:53:38

Dyne Therapeutics reported promising Phase 1/2 trial data for DYNE-101 in myotonic dystrophy type 1 and DYNE-251 in Duchenne mu...

Jefferies Maintains Buy on Dyne Therapeuti...
05/20/2024 17:32:17

Jefferies maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and raises the price target from $36 to $42.

overseas-shipholding-micron-squarespace-incyte-and-other-big-stocks-moving-higher-on-monday

Overseas Shipholding, Micron, Squarespace,...
05/20/2024 15:37:53

HC Wainwright & Co. Maintains Buy on Dyne ...
05/20/2024 13:33:21

HC Wainwright & Co. analyst Andrew Fein maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and raises the price target ...

Market-Moving News for May 20th
05/20/2024 12:37:59

PTCT: 27% | PTC Therapeutics Announces European Commission Returns Translarna Opinion to CHMP For Re-evaluation NKGN: 81% | NK...

Dyne Therapeutics Announced Clinical Data ...
05/20/2024 10:33:32

In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 ...

Reported Sunday, Dyne Therapeutics Announc...
05/20/2024 05:48:39

Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage muscle disease company focused on advancing innovative life-transformin...

Chardan Capital Maintains Buy on Dyne Ther...
05/06/2024 12:03:57

Chardan Capital analyst Keay Nakae maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and maintains $31 price target.

Oppenheimer Reiterates Outperform on Dyne ...
05/06/2024 11:55:31

Oppenheimer analyst Francois Brisebois reiterates Dyne Therapeutics (NASDAQ:DYN) with a Outperform and maintains $47 price t...

HC Wainwright & Co. Reiterates Buy on Dyne...
05/03/2024 19:46:57

HC Wainwright & Co. analyst Andrew Fein reiterates Dyne Therapeutics (NASDAQ:DYN) with a Buy and maintains $36 price tar...

Morgan Stanley Initiates Coverage On Dyne ...
04/30/2024 09:17:22

Morgan Stanley analyst Michael Ulz initiates coverage on Dyne Therapeutics (NASDAQ:DYN) with a Overweight rating and announc...

Oppenheimer Reiterates Outperform on Dyne ...
03/26/2024 14:07:28

Oppenheimer analyst Francois Brisebois reiterates Dyne Therapeutics (NASDAQ:DYN) with a Outperform and maintains $47 price t...

why-landos-biopharma-shares-are-trading-higher-by-over-170-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Landos Biopharma Shares Are Trading Hi...
03/25/2024 18:44:08

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

aehr-test-systems-reports-preliminary-results-joins-dyne-therapeutics-united-airlines-and-other-big-stocks-moving-lower-on-monday

Aehr Test Systems Reports Preliminary Resu...
03/25/2024 14:32:02

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.

Dyne Therapeutics Has Appointed John Cox A...
03/25/2024 11:34:39

neuromuscular-focused-avidity-biosciences-has-complete-package---analyst-predicts-stellar-142-stock-surge

Neuromuscular Focused-Avidity Biosciences ...
03/14/2024 19:29:25

Cantor Fitzgerald initiates coverage on Avidity Biosciences highlighting a robust pipeline led by del-desiran, a promising trea...

Chardan Capital Maintains Buy Rating for D...
03/08/2024 17:00:24

Chardan Capital Maintains Buy on Dyne Ther...
03/08/2024 08:58:16

Chardan Capital maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and raises the price target from $20 to $31.

Guggenheim Maintains Buy on Dyne Therapeut...
03/07/2024 16:19:00

Guggenheim analyst Debjit Chattopadhyay maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy and raises the price target from...